Diffuse paediatric-type high-grade gliomas, H3-wildtype and IDH-wildtype can be further subclassified into three subtypes: RTK1 (Receptor of Tyrosine Kinase-1), RTK2, and MYCN, each with typical molecular alterations. The gene discussed is IDH2; the disease is central nervous system cancer.